Welcome to LookChem.com Sign In|Join Free

CAS

  • or

21900-33-4

Post Buying Request

21900-33-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21900-33-4 Usage

Description

3-Bromo-4-methyl-benzoyl chloride, with the chemical formula C8H6BrClO, is an organic compound that falls under the category of benzoyl chlorides. It is a colorless to pale yellow liquid with a pungent odor and is highly reactive, making it a valuable intermediate in various chemical syntheses.

Uses

Used in Pharmaceutical Industry:
3-Bromo-4-methyl-benzoyl chloride is used as a key intermediate in the synthesis of pharmaceuticals. Its reactivity allows it to form bonds with other molecules, facilitating the creation of new drug compounds.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Bromo-4-methyl-benzoyl chloride serves as an essential intermediate for the production of various agrochemicals. Its ability to react with other molecules contributes to the development of new compounds for agricultural applications.
Used in Organic Synthesis:
3-Bromo-4-methyl-benzoyl chloride is utilized as a versatile intermediate in organic synthesis for creating a range of organic compounds. Its high reactivity makes it suitable for forming bonds and constructing complex molecular structures.
It is crucial to handle 3-Bromo-4-methyl-benzoyl chloride with care due to its corrosive nature, which can cause skin and eye irritation upon contact. Proper safety measures should be taken to minimize risks during its use in various applications.

Check Digit Verification of cas no

The CAS Registry Mumber 21900-33-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,9,0 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 21900-33:
(7*2)+(6*1)+(5*9)+(4*0)+(3*0)+(2*3)+(1*3)=74
74 % 10 = 4
So 21900-33-4 is a valid CAS Registry Number.

21900-33-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-BROMO-4-METHYL-BENZOYL CHLORIDE

1.2 Other means of identification

Product number -
Other names 3-Brom-4'-methylbenzophenon

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21900-33-4 SDS

21900-33-4Relevant articles and documents

Design and Discovery of N-(2-Methyl-5′-morpholino-6′-((tetrahydro-2H-pyran-4-yl)oxy)-[3,3′-bipyridin]-5-yl)-3-(trifluoromethyl)benzamide (RAF709): A Potent, Selective, and Efficacious RAF Inhibitor Targeting RAS Mutant Cancers

Nishiguchi, Gisele A.,Rico, Alice,Tanner, Huw,Aversa, Robert J.,Taft, Benjamin R.,Subramanian, Sharadha,Setti, Lina,Burger, Matthew T.,Wan, Lifeng,Tamez, Victoriano,Smith, Aaron,Lou, Yan,Barsanti, Paul A.,Appleton, Brent A.,Mamo, Mulugeta,Tandeske, Laura,Dix, Ina,Tellew, John E.,Huang, Shenlin,Mathews Griner, Lesley A.,Cooke, Vesselina G.,Van Abbema, Anne,Merritt, Hanne,Ma, Sylvia,Gampa, Kalyani,Feng, Fei,Yuan, Jing,Wang, Yingyun,Haling, Jacob R.,Vaziri, Sepideh,Hekmat-Nejad, Mohammad,Jansen, Johanna M.,Polyakov, Valery,Zang, Richard,Sethuraman, Vijay,Amiri, Payman,Singh, Mallika,Lees, Emma,Shao, Wenlin,Stuart, Darrin D.,Dillon, Michael P.,Ramurthy, Savithri

, p. 4869 - 4881 (2017)

RAS oncogenes have been implicated in >30% of human cancers, all representing high unmet medical need. The exquisite dependency on CRAF kinase in KRAS mutant tumors has been established in genetically engineered mouse models and human tumor cells. To date

RECEPTOR TYROSINE KINASE INHIBITORS FOR TREATMENT OF PROTEIN KINASE MODULATION-RESPONSIVE DISEASE OR DISORDER

-

Page/Page column 58; 59; 71; 72; 74; 75; 77; 78, (2021/03/19)

Ephrin type receptor tyrosine kinase inhibitors, also known as Eph tyrosine kinase receptor inhibitors, for treating cancer, an inflammatory disease, an autoimmune disease, or a degenerative disease characterized at least in part by the abnormal activity

Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 2. Ketone Linked Analogs

Carter, David S.,Jacobs, Robert T.,Freund, Yvonne R.,Berry, Pamela W.,Akama, Tsutomu,Easom, Eric E.,Lunde, Christopher S.,Rock, Fernando,Stefanakis, Rianna,Mckerrow, James,Fischer, Chelsea,Bulman, Christina A.,Lim, Kee Chong,Suzuki, Brian M.,Tricoche, Nancy,Sakanari, Judy A.,Lustigman, Sara,Plattner, Jacob J.

, p. 180 - 185 (2020/02/13)

The optimization of a series of benzimidazole-benzoxaborole hybrid molecules linked via a ketone that exhibit good activity against Onchocerca volvulus, a filarial nematode responsible for the disease onchocerciasis, also known as river blindness, is desc

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 21900-33-4